Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeodomain-interacting protein kinase 3 (HIPK3) is a serine/threonine-protein kinase belonging to the CMGC kinase family and is closely related to the dual-specificity tyrosine phosphorylation-regulated kinases. HIPK3 is primarily located in the cytosol, nuclear body, and plasma membrane. It participates in the regulation of gene transcription, protein phosphorylation, and negative control of apoptosis through phosphorylation of key substrates such as JUN and RUNX2. HIPK3 also acts as a transcriptional co-regulator for homeodomain-containing transcription factors and steroidogenic genes, modulating pathways involved in cell proliferation, apoptosis, and tissue development. Dysregulation of HIPK3 or its circular RNA (circHIPK3) is implicated in various human diseases, including cancers, cataract, diabetes, neurodegenerative disorders, and fibrotic or proliferative ocular pathologies
Inhibition of kinase activity (as with abemaciclib binding to HIPK3, blocks phosphorylation of downstream transcription factors and co-regulators)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeodomain-interacting protein kinase 3 (HIPK3).